Official Medical Fee Schedule - Pharmaceuticals regulations

Workers' compensation proposed regulations
Official Medical Fee Schedule - Pharmaceuticals
Title 8, California Code of Regulations
Section 9789.40

Filed with Office of Administrative Law Feb. 13, 2007
Effective Mar. 1, 2007

Final statement of reasons version version
Final text of regulations version version
Notice of modification to text of regulations version version

Comment chart
45 day written comments version version
45 day oral comments version version

History of Official Medical Fee Schedule - Pharmaceuticals

Transcript of public hearing testimony version

45 day comment period - Oct 31, 2006

Notice of documents added to the rulemaking file

Proposed regulations version version

1. Wilson L, Gitlin M., “New Workers' Compensation Legislation: Expected Pharmaceutical Cost Savings,” American Journal of Industrial Medicine, 2005;48(4):239 - 48 version
2. Matthew Gitlin, Pharm.D., Leslie Wilson, Ph.D., “The Pricing and Distribution of Repackaged Drugs: Cost Effects to the California Workers’ Compensation System, Payers and Providers,” Payers and Providers. Department of Clinical Pharmacy, University of California, San Francisco, 94143 version

3. Gitlin M., Wilson L., “Repackaged Pharmaceuticals in the California Workers’ Compensation System: From Distribution and Pricing Options to Physician and Retail Dispensing,“ American Journal of Industrial Medicine, pending revisions version
   

Notice of proposed rulemaking version version
Initial statement of reasons version version
Text of proposed regulations version version

Time and place of public hearing

A public hearing has been scheduled to permit all interested persons the opportunity to present statements, arguments, either orally or in writing, with respect to the subject noted above. The hearing will be held at the following time and place:

Camera usage will be allowed in only one area of the hearing room. To provide everyone a chance to speak, public testimony will be limited to 10 minutes per speaker and should be specific to the proposed regulations. Testimony exceeding 10 minutes may be submitted in writing.

Written comments should be addressed to:

Maureen Gray, regulations coordinator
Department of Industrial Relations
Division of Workers' Compensation
1515 Clay Street, 18th floor
Oakland, CA 94162

The division's contact person must receive all written comments concerning the proposed modifications to the regulations no later 5:00 p. m. on Tuesday, Oct. 31, 2006. Written comments may be submitted by facsimile transmission (FAX), addressed to the contact person at (510) 286-0687. Written comments may also be sent electronically (via e-mail), using the following e-mail address: dwcrules@hq.dir.ca.gov.